TTI-1612 / Pfizer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TTI-1612 / Pfizer
NCT01559961: Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome

Completed
1
28
Canada
TTI-1612
Trillium Therapeutics Inc.
Interstitial Cystitis
02/13
06/13

Download Options